{
    "clinical_study": {
        "@rank": "33351", 
        "arm_group": {
            "arm_group_label": "Freedom Cervical Disc", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study will collect clinical and radiographic data on the Freedom Cervical Disc to\n      monitor the device's safety and performance as part of a post-market evaluation."
        }, 
        "brief_title": "Freedom\u00ae Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Symptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Diseases", 
                "Intervertebral Disk Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Skeletally mature males or females, aged 21 to 65 years old, inclusive.\n\n          -  Single, or adjacent, 2-level degenerative disc disease at C3-C7, inclusive.\n\n          -  Subject is a surgical candidate for an anterior approach to the cervical  spine.\n\n          -  Minimum of 6 weeks of unsuccessful conservative treatment.\n\n          -  Subject with at least moderate preoperative pain and functional impairment\n\n          -  Subject is mentally and physically able to comply with protocol, postoperative\n             compliance instructions, and follow-up schedule through 2-years.\n\n          -  Subject must understand and sign the written Informed Consent form.\n\n        Exclusion Criteria:\n\n          -  Subject with axial neck pain only who does not demonstrate concurrent arm pain or\n             progressive neurological deterioration (specifically numbness or muscle weakness in\n             the arm).\n\n          -  An active infection at the operative site or active systemic infection at the time of\n             surgery.\n\n          -  Known or suspected allergy to titanium, polyurethane, cobalt, chromium, molybdenum or\n             silicone.\n\n          -  Previous spinal fusion at the involved, or adjacent, cervical level(s).\n\n          -  Congenital or acquired structural defect at the operative levels (s) or their\n             immediately adjacent level(s).\n\n          -  Significant osteoporosis in the cervical spine.\n\n          -  The investigator should assess if the subject has any of the following conditions at\n             the index or adjacent level(s) which excludes the subject from study participation:\n\n          -  Cervical facet degeneration of the involved C3-C7 levels.\n\n          -  Previous trauma to, or fusion in, the C3-C7 levels.\n\n          -  Cervical instability at the index level(s) on neutral lateral or flexion/extension\n             x-rays.\n\n          -  Radiographic findings of a fused or total collapsed disc.\n\n          -  Significant global cervical kyphosis (\u226515\u00ba on Cobb angle measurement) or significant\n             reversal of lordosis.\n\n          -  Female of childbearing potential, pregnant, breast feeding, or interested in becoming\n             pregnant in the next two years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01763619", 
            "org_study_id": "PR-300"
        }, 
        "intervention": {
            "arm_group_label": "Freedom Cervical Disc", 
            "intervention_name": "Freedom Cervical Disc", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cervical DDD", 
            "DDD", 
            "degenerative disc disease", 
            "C3-C7"
        ], 
        "lastchanged_date": "April 23, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Robert Pflugmacher, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53105"
                    }, 
                    "name": "Universitatsklinikum Bonn"
                }, 
                "investigator": {
                    "last_name": "Robert Pflugmacher, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marcus Eif, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gorlitz", 
                        "country": "Germany", 
                        "zip": "02828"
                    }, 
                    "name": "Stadtisches Klinikum Gorlitz"
                }, 
                "investigator": {
                    "last_name": "Marcus Eif, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "George Kiriyanthan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Karlsruhe", 
                        "country": "Germany", 
                        "zip": "76133"
                    }, 
                    "name": "Stadtisches Klinikum Karlsruhe"
                }, 
                "investigator": {
                    "last_name": "George Kiriyanthan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Oliver Hausmann, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Luzern", 
                        "country": "Switzerland", 
                        "zip": "CH-6006"
                    }, 
                    "name": "Klinik St. Anna"
                }, 
                "investigator": {
                    "last_name": "Oliver Hausmann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Burkhard Rischke, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "CH 8001"
                    }, 
                    "name": "Spine Center Rischke"
                }, 
                "investigator": {
                    "last_name": "Burkhard Rischke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Switzerland"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Freedom\u00ae Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease", 
        "overall_contact": {
            "email": "ndefibaugh@axiomed.com", 
            "last_name": "Neal Defibaugh", 
            "phone": "2165875566"
        }, 
        "overall_contact_backup": {
            "email": "cmaguire@axiomed.com", 
            "last_name": "Courtney Maguire", 
            "phone": "2165875566"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Switzerland: Ethikkommission", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Monitor the safety (operative and post-operative adverse events through 6-months) of the FCD.", 
                "measure": "Safety of FCD", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Monitor the performance (radiographic evaluation of segmental non-fusion and device function) of the FCD through 6-months post-operative period.", 
                "measure": "Performance of FCD", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01763619"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Examine the incidence of adverse events including device revision, removal or supplemental fixation through the 2-years post-operative period.", 
                "measure": "Incidence of AEs", 
                "safety_issue": "Yes", 
                "time_frame": "2 year"
            }, 
            {
                "description": "Examine changes in neck and arm pain throughout the 2-years post-operative period.", 
                "measure": "Neck/Arm Pain", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Examine changes in subject neurological function throughout the 2-years post-operative period.", 
                "measure": "Neurological function", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Examine changes in subject function throughout the 2-years post-operative period.", 
                "measure": "Subject Function", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Examine changes in radiographic measurements of the target, adjacent and cervical segment levels from discharge through the 2-years.", 
                "measure": "Radiographic Measurements", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Examine all adverse events throughout the 2-years post-operative period", 
                "measure": "Examine AEs", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }
        ], 
        "source": "AxioMed Spine Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AxioMed Spine Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}